{"id":350423,"date":"2026-11-17T14:49:04","date_gmt":"2026-11-17T09:19:04","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=350423"},"modified":"2026-11-17T14:49:04","modified_gmt":"2026-11-17T09:19:04","slug":"cement-and-wall-putty-maker-pharmaceutical-ingredients-company-and-defence-explosives-maker-stocks-roadmap-downland-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/cement-and-wall-putty-maker-pharmaceutical-ingredients-company-and-defence-explosives-maker-stocks-roadmap-downland-list\/","title":{"rendered":"3 Cement and Wall Putty Maker, Pharmaceutical Ingredients Company and Defence Explosives Maker Stocks With a Strong Future Roadmap: JK Cement, Granules India and Premier Explosives"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>JK Cement, Granules India and Premier Explosives: ROE of 11.7% to 15.8% and FY22 to FY26 revenue CAGR of 9.2% to 20.8%. Prices as of 16 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three <strong>cement, drug ingredient and explosives stocks<\/strong> to watch are <strong>JK Cement<\/strong>, <strong>Granules India<\/strong> and <strong>Premier Explosives<\/strong>. Their <strong>return on equity<\/strong> ranges from <strong>11.7% to 15.8%<\/strong>, and their <strong>revenue compound annual growth<\/strong> from FY22 to FY26 ranges from 9.2% to 20.8%. Premier Explosives leads on both return on equity at 15.8% and revenue growth at 20.8% a year. Prices are based on the 16 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Cement, drug ingredient and explosives stocks offer a focused view of a sector where demand keeps widening. JK Cement, Granules India and Premier Explosives cover a cement and wall putty maker, a pharmaceutical ingredients company and a defence explosives maker.<\/p>\n<p>This list covers three cement, drug ingredient and explosives stocks with complete current figures: JK Cement, Granules India and Premier Explosives. Every figure comes from the latest reported financials and the 16 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=cement-and-wall-putty-maker-pharmaceutical-ingredients-company-and-defence-explosives-maker-stocks-roadmap-downland-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/cement-and-wall-putty-maker-pharmaceutical-ingredients-company-and-defence-explosives-maker-stocks-roadmap-downland-list\/#What_Are_Cement_Drug_Ingredient_and_Explosives_Stocks\" title=\"What Are Cement, Drug Ingredient and Explosives Stocks?\">What Are Cement, Drug Ingredient and Explosives Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/cement-and-wall-putty-maker-pharmaceutical-ingredients-company-and-defence-explosives-maker-stocks-roadmap-downland-list\/#Cement_Drug_Ingredient_and_Explosives_Stocks_at_a_Glance\" title=\"Cement, Drug Ingredient and Explosives Stocks at a Glance\">Cement, Drug Ingredient and Explosives Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/cement-and-wall-putty-maker-pharmaceutical-ingredients-company-and-defence-explosives-maker-stocks-roadmap-downland-list\/#Why_Do_Cement_Drug_Ingredient_and_Explosives_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Cement, Drug Ingredient and Explosives Stocks Have a Strong Roadmap in India?\">Why Do Cement, Drug Ingredient and Explosives Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/cement-and-wall-putty-maker-pharmaceutical-ingredients-company-and-defence-explosives-maker-stocks-roadmap-downland-list\/#Why_JK_Cement_Features_Among_These_Cement_Drug_Ingredient_and_Explosives_Stocks\" title=\"Why JK Cement Features Among These Cement, Drug Ingredient and Explosives Stocks\">Why JK Cement Features Among These Cement, Drug Ingredient and Explosives Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/cement-and-wall-putty-maker-pharmaceutical-ingredients-company-and-defence-explosives-maker-stocks-roadmap-downland-list\/#Why_Granules_India_Features_Among_These_Cement_Drug_Ingredient_and_Explosives_Stocks\" title=\"Why Granules India Features Among These Cement, Drug Ingredient and Explosives Stocks\">Why Granules India Features Among These Cement, Drug Ingredient and Explosives Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/cement-and-wall-putty-maker-pharmaceutical-ingredients-company-and-defence-explosives-maker-stocks-roadmap-downland-list\/#Why_Premier_Explosives_Features_Among_These_Cement_Drug_Ingredient_and_Explosives_Stocks\" title=\"Why Premier Explosives Features Among These Cement, Drug Ingredient and Explosives Stocks\">Why Premier Explosives Features Among These Cement, Drug Ingredient and Explosives Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/cement-and-wall-putty-maker-pharmaceutical-ingredients-company-and-defence-explosives-maker-stocks-roadmap-downland-list\/#JK_Cement_vs_Granules_India_vs_Premier_Explosives_on_Key_Financials\" title=\"JK Cement vs Granules India vs Premier Explosives on Key Financials\">JK Cement vs Granules India vs Premier Explosives on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/cement-and-wall-putty-maker-pharmaceutical-ingredients-company-and-defence-explosives-maker-stocks-roadmap-downland-list\/#Key_Risks_to_Check_Before_Investing_in_Cement_Drug_Ingredient_and_Explosives_Stocks\" title=\"Key Risks to Check Before Investing in Cement, Drug Ingredient and Explosives Stocks\">Key Risks to Check Before Investing in Cement, Drug Ingredient and Explosives Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/cement-and-wall-putty-maker-pharmaceutical-ingredients-company-and-defence-explosives-maker-stocks-roadmap-downland-list\/#Final_Thoughts_on_Cement_Drug_Ingredient_and_Explosives_Stocks\" title=\"Final Thoughts on Cement, Drug Ingredient and Explosives Stocks\">Final Thoughts on Cement, Drug Ingredient and Explosives Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/cement-and-wall-putty-maker-pharmaceutical-ingredients-company-and-defence-explosives-maker-stocks-roadmap-downland-list\/#What_are_cement_drug_ingredient_and_explosives_stocks\" title=\"What are cement, drug ingredient and explosives stocks?\">What are cement, drug ingredient and explosives stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/cement-and-wall-putty-maker-pharmaceutical-ingredients-company-and-defence-explosives-maker-stocks-roadmap-downland-list\/#Which_cement_drug_ingredient_and_explosives_stocks_are_covered_in_this_list\" title=\"Which cement, drug ingredient and explosives stocks are covered in this list?\">Which cement, drug ingredient and explosives stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/cement-and-wall-putty-maker-pharmaceutical-ingredients-company-and-defence-explosives-maker-stocks-roadmap-downland-list\/#Why_do_cement_drug_ingredient_and_explosives_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do cement, drug ingredient and explosives stocks have a strong future roadmap in India?\">Why do cement, drug ingredient and explosives stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/cement-and-wall-putty-maker-pharmaceutical-ingredients-company-and-defence-explosives-maker-stocks-roadmap-downland-list\/#How_has_JK_Cement_performed_financially\" title=\"How has JK Cement performed financially?\">How has JK Cement performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/cement-and-wall-putty-maker-pharmaceutical-ingredients-company-and-defence-explosives-maker-stocks-roadmap-downland-list\/#How_has_Granules_India_performed_financially\" title=\"How has Granules India performed financially?\">How has Granules India performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/cement-and-wall-putty-maker-pharmaceutical-ingredients-company-and-defence-explosives-maker-stocks-roadmap-downland-list\/#How_has_Premier_Explosives_performed_financially\" title=\"How has Premier Explosives performed financially?\">How has Premier Explosives performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/cement-and-wall-putty-maker-pharmaceutical-ingredients-company-and-defence-explosives-maker-stocks-roadmap-downland-list\/#What_risks_should_investors_check_before_buying_cement_drug_ingredient_and_explosives_stocks\" title=\"What risks should investors check before buying cement, drug ingredient and explosives stocks?\">What risks should investors check before buying cement, drug ingredient and explosives stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/cement-and-wall-putty-maker-pharmaceutical-ingredients-company-and-defence-explosives-maker-stocks-roadmap-downland-list\/#Is_this_list_of_cement_drug_ingredient_and_explosives_stocks_investment_advice\" title=\"Is this list of cement, drug ingredient and explosives stocks investment advice?\">Is this list of cement, drug ingredient and explosives stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Cement_Drug_Ingredient_and_Explosives_Stocks\"><\/span><strong>What Are Cement, Drug Ingredient and Explosives Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Cement, drug ingredient and explosives stocks<\/strong> are listed companies that make grey and white cement and wall putty for homes and infrastructure, make pharmaceutical ingredients and finished tablets, and make propellants and explosives for defence and space programmes. Their earnings depend on construction activity, medicine demand and defence orders.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Cement_Drug_Ingredient_and_Explosives_Stocks_at_a_Glance\"><\/span><strong>Cement, Drug Ingredient and Explosives Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/jkcement\/jk-cement-ltd-share-price-today\">JK Cement<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,252.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">37,671<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">40.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">29.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.88<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/granules\/granules-india-ltd-share-price-today\">Granules India<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">798.95<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">22,002<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">33.2<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.30<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/premexpln\/premier-explosives-ltd-share-price-today\">Premier Explosives<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">554.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,722<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">111.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">48.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.11<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, Granules India trades at a <strong>P\/E<\/strong> below the industry P\/E, while JK Cement and Premier Explosives trade above it, which reflects the growth the market already expects. Readers comparing cement, drug ingredient and explosives stocks should look at <strong>return on equity<\/strong> and debt together, since a high return earned with low debt is easier to sustain.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Cement_Drug_Ingredient_and_Explosives_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Cement, Drug Ingredient and Explosives Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Cement, drug ingredient and explosives stocks have a strong roadmap in India because heavy spending on housing and roads, steady demand for essential medicines and rising defence and space spending keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Cement and putty.<\/strong> Roads and homes need quality finishing.<\/li>\n<li><strong>Pharma ingredients.<\/strong> Medicine makers need reliable supply.<\/li>\n<li><strong>Defence explosives.<\/strong> Defence programmes need dependable propellants.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_JK_Cement_Features_Among_These_Cement_Drug_Ingredient_and_Explosives_Stocks\"><\/span><strong>Why JK Cement Features Among These Cement, Drug Ingredient and Explosives Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the <strong>cement, drug ingredient and explosives stocks<\/strong> on this list, JK Cement is a cement and building products company with plants in northern, western and southern India. It sells grey cement, white cement and wall putty, and it has a strong presence in the premium white cement segment.<\/p>\n<p>Revenue rose from Rs 8,134 crore in FY22 to Rs 13,917 crore in FY26, a compound annual growth rate of 14.4%. Net profit grew from Rs 679 crore in FY22 to Rs 988 crore in FY26, which works out to a compound annual growth rate of 9.8%.<\/p>\n<p>In the June 2026 quarter, revenue grew 19.4% year on year to Rs 4,071 crore. The company has a return on equity of 14.1%, a debt to equity ratio of 0.88 and a <strong>market capitalisation<\/strong> of Rs 37,671 crore. The stock trades at a <strong>P\/E<\/strong> of 40.1, above the industry P\/E of 29.1.<\/p>\n<p><strong>Roadmap:<\/strong> The company is expanding grey cement capacity in several regions and growing its white cement and putty range, which carries a strong brand. Housing and infrastructure activity supports steady cement demand.<\/p>\n<p><strong>What to watch:<\/strong> Track capacity additions, volume growth and realisation per tonne.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Granules_India_Features_Among_These_Cement_Drug_Ingredient_and_Explosives_Stocks\"><\/span><strong>Why Granules India Features Among These Cement, Drug Ingredient and Explosives Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the building cement, tablet maker and defence propellant shares on this list, Granules India is a Hyderabad-based pharmaceutical manufacturer that makes active ingredients, intermediates and finished dosage forms, with a strong position in paracetamol, metformin and ibuprofen.<\/p>\n<p>In the June 2026 quarter, revenue grew 20.6% year on year to Rs 1,479 crore, while net profit rose 59.8% to Rs 180 crore. Revenue rose from Rs 3,783 crore in FY22 to Rs 5,386 crore in FY26, a compound annual growth rate of 9.2%.<\/p>\n<p>Net profit grew from Rs 413 crore in FY22 to Rs 595 crore in FY26, which works out to a compound annual growth rate of 9.6%. The company has a return on equity of 11.7%, a debt to equity ratio of 0.30 and a market capitalisation of Rs 22,002 crore. The stock trades at a P\/E of 33.2, below the industry P\/E of 36.0.<\/p>\n<p><strong>Roadmap:<\/strong> The company is shifting its mix towards finished dosages, which earn better margins than ingredients, and it supplies customers in regulated markets, especially the United States. Capacity additions and new product approvals support steady growth.<\/p>\n<p><strong>What to watch:<\/strong> Monitor new product approvals and the share of finished dosages in total sales.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Premier_Explosives_Features_Among_These_Cement_Drug_Ingredient_and_Explosives_Stocks\"><\/span><strong>Why Premier Explosives Features Among These Cement, Drug Ingredient and Explosives Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Premier Explosives makes industrial explosives, detonators, propellants and defence products, and is a supplier of rocket motors and solid propellants for strategic and space programmes.<\/p>\n<p>The company has a return on equity of 15.8%, a debt to equity ratio of 0.11 and a market capitalisation of Rs 3,722 crore. The stock trades at a P\/E of 111.0, above the industry P\/E of 48.1.<\/p>\n<p>Revenue rose from Rs 202 crore in FY22 to Rs 430 crore in FY26, a compound annual growth rate of 20.8%. Net profit grew from Rs 5.2 crore in FY22 to Rs 45.8 crore in FY26, which works out to a compound annual growth rate of 72.1%.<\/p>\n<p><strong>Roadmap:<\/strong> The company is moving up the value chain into defence and space propellants, which carry higher margins than civil explosives. Orders from strategic programmes and capacity expansion support the plan.<\/p>\n<p><strong>What to watch:<\/strong> Check the execution of defence and space orders, which can be uneven from one quarter to the next.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"JK_Cement_vs_Granules_India_vs_Premier_Explosives_on_Key_Financials\"><\/span><strong>JK Cement vs Granules India vs Premier Explosives on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three cement, drug ingredient and explosives stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">JK Cement<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8,134<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13,917<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14.4%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">988<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Granules India<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,783<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,386<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.2%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">595<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.0%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Premier Explosives<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">202<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">430<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.8%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">45.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.6%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Premier Explosives posts the highest return on equity in this group at 15.8%. JK Cement has the largest FY26 revenue at Rs 13,917 crore, and Premier Explosives shows the fastest revenue growth with a 20.8% compound annual rate. A useful habit with cement, drug ingredient and explosives stocks is to check each new quarterly result against the capacity plans the company described earlier.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Cement_Drug_Ingredient_and_Explosives_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Cement, Drug Ingredient and Explosives Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these <strong>cement, drug ingredient and explosives stocks<\/strong>, the main points are: Long-term building cement, tablet maker and defence propellant shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Raw material costs.<\/strong> Ingredient and packaging prices can move margins.<\/li>\n<li><strong>Regulatory approvals.<\/strong> Plant inspections and approvals can affect supplies.<\/li>\n<li><strong>Order timing.<\/strong> Defence and space orders can shift between periods.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter cement, drug ingredient and explosives stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Cement_Drug_Ingredient_and_Explosives_Stocks\"><\/span><strong>Final Thoughts on Cement, Drug Ingredient and Explosives Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Cement, drug ingredient and explosives stocks reward patient research into demand, execution and financial strength. JK Cement, Granules India and Premier Explosives each have a clear plan to grow. Based on the 16 November 2026 close, JK Cement trades at Rs 5,252.6, Granules India at Rs 798.95 and Premier Explosives at Rs 554.4.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track cement, drug ingredient and explosives stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_cement_drug_ingredient_and_explosives_stocks\"><\/span><strong>What are cement, drug ingredient and explosives stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> <strong>Cement, drug ingredient and explosives stocks<\/strong> are listed companies that make grey and white cement and wall putty for homes and infrastructure, make pharmaceutical ingredients and finished tablets, and make propellants and explosives for defence and space programmes. Their earnings depend on construction activity, medicine demand and defence orders. This list looks at three of them, JK Cement, Granules India and Premier Explosives, using reported FY22 to FY26 financials and the 16 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_cement_drug_ingredient_and_explosives_stocks_are_covered_in_this_list\"><\/span><strong>Which cement, drug ingredient and explosives stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers JK Cement, Granules India and Premier Explosives. Based on the 16 November 2026 close, JK Cement traded at Rs 5,252.6, Granules India at Rs 798.95 and Premier Explosives at Rs 554.4. Their return on equity ranges from <strong>11.7% to 15.8%<\/strong>, and their <strong>revenue compound annual growth<\/strong> from FY22 to FY26 ranges from 9.2% to 20.8%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_cement_drug_ingredient_and_explosives_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do cement, drug ingredient and explosives stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Cement, drug ingredient and explosives stocks have a strong roadmap in India because heavy spending on housing and roads, steady demand for essential medicines and rising defence and space spending keep widening the market for these companies. The main drivers are as follows. Cement and putty. Roads and homes need quality finishing. Pharma ingredients. Medicine makers need reliable supply. Defence explosives. Defence programmes need dependable propellants. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_JK_Cement_performed_financially\"><\/span><strong>How has JK Cement performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 8,134 crore in FY22 to Rs 13,917 crore in FY26, a compound annual growth rate of 14.4%. Net profit grew from Rs 679 crore in FY22 to Rs 988 crore in FY26, which works out to a compound annual growth rate of 9.8%. In the June 2026 quarter, revenue grew 19.4% year on year to Rs 4,071 crore. The company has a return on equity of 14.1%, a debt to equity ratio of 0.88 and a market capitalisation of Rs 37,671 crore. The stock trades at a P\/E of 40.1, above the industry P\/E of 29.1. Looking ahead, the company is expanding grey cement capacity in several regions and growing its white cement and putty range, which carries a strong brand. Housing and infrastructure activity supports steady cement demand.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Granules_India_performed_financially\"><\/span><strong>How has Granules India performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 3,783 crore in FY22 to Rs 5,386 crore in FY26, a compound annual growth rate of 9.2%. Net profit grew from Rs 413 crore in FY22 to Rs 595 crore in FY26, which works out to a compound annual growth rate of 9.6%. In the June 2026 quarter, revenue grew 20.6% year on year to Rs 1,479 crore, while net profit rose 59.8% to Rs 180 crore. The company has a return on equity of 11.7%, a debt to equity ratio of 0.30 and a market capitalisation of Rs 22,002 crore. The stock trades at a P\/E of 33.2, below the industry P\/E of 36.0. Looking ahead, the company is shifting its mix towards finished dosages, which earn better margins than ingredients, and it supplies customers in regulated markets, especially the United States. Capacity additions and new product approvals support steady growth.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Premier_Explosives_performed_financially\"><\/span><strong>How has Premier Explosives performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 202 crore in FY22 to Rs 430 crore in FY26, a compound annual growth rate of 20.8%. Net profit grew from Rs 5.2 crore in FY22 to Rs 45.8 crore in FY26, which works out to a compound annual growth rate of 72.1%. The company has a return on equity of 15.8%, a debt to equity ratio of 0.11 and a market capitalisation of Rs 3,722 crore. The stock trades at a P\/E of 111.0, above the industry P\/E of 48.1. Looking ahead, the company is moving up the value chain into defence and space propellants, which carry higher margins than civil explosives. Orders from strategic programmes and capacity expansion support the plan.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_cement_drug_ingredient_and_explosives_stocks\"><\/span><strong>What risks should investors check before buying cement, drug ingredient and explosives stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying cement, drug ingredient and explosives stocks. Raw material costs. Ingredient and packaging prices can move margins. Regulatory approvals. Plant inspections and approvals can affect supplies. Order timing. Defence and space orders can shift between periods. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_cement_drug_ingredient_and_explosives_stocks_investment_advice\"><\/span><strong>Is this list of cement, drug ingredient and explosives stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 16 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are cement, drug ingredient and explosives stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Cement, drug ingredient and explosives stocks are listed companies that make grey and white cement and wall putty for homes and infrastructure, make pharmaceutical ingredients and finished tablets, and make propellants and explosives for defence and space programmes. Their earnings depend on construction activity, medicine demand and defence orders. This list looks at three of them, JK Cement, Granules India and Premier Explosives, using reported FY22 to FY26 financials and the 16 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which cement, drug ingredient and explosives stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers JK Cement, Granules India and Premier Explosives. Based on the 16 November 2026 close, JK Cement traded at Rs 5,252.6, Granules India at Rs 798.95 and Premier Explosives at Rs 554.4. Their return on equity ranges from 11.7% to 15.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 9.2% to 20.8%.\"}},{\"@type\":\"Question\",\"name\":\"Why do cement, drug ingredient and explosives stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Cement, drug ingredient and explosives stocks have a strong roadmap in India because heavy spending on housing and roads, steady demand for essential medicines and rising defence and space spending keep widening the market for these companies. The main drivers are as follows. Cement and putty. Roads and homes need quality finishing. Pharma ingredients. Medicine makers need reliable supply. Defence explosives. Defence programmes need dependable propellants. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has JK Cement performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 8,134 crore in FY22 to Rs 13,917 crore in FY26, a compound annual growth rate of 14.4%. Net profit grew from Rs 679 crore in FY22 to Rs 988 crore in FY26, which works out to a compound annual growth rate of 9.8%. In the June 2026 quarter, revenue grew 19.4% year on year to Rs 4,071 crore. The company has a return on equity of 14.1%, a debt to equity ratio of 0.88 and a market capitalisation of Rs 37,671 crore. The stock trades at a P\/E of 40.1, above the industry P\/E of 29.1. Looking ahead, the company is expanding grey cement capacity in several regions and growing its white cement and putty range, which carries a strong brand. Housing and infrastructure activity supports steady cement demand.\"}},{\"@type\":\"Question\",\"name\":\"How has Granules India performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 3,783 crore in FY22 to Rs 5,386 crore in FY26, a compound annual growth rate of 9.2%. Net profit grew from Rs 413 crore in FY22 to Rs 595 crore in FY26, which works out to a compound annual growth rate of 9.6%. In the June 2026 quarter, revenue grew 20.6% year on year to Rs 1,479 crore, while net profit rose 59.8% to Rs 180 crore. The company has a return on equity of 11.7%, a debt to equity ratio of 0.30 and a market capitalisation of Rs 22,002 crore. The stock trades at a P\/E of 33.2, below the industry P\/E of 36.0. Looking ahead, the company is shifting its mix towards finished dosages, which earn better margins than ingredients, and it supplies customers in regulated markets, especially the United States. Capacity additions and new product approvals support steady growth.\"}},{\"@type\":\"Question\",\"name\":\"How has Premier Explosives performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 202 crore in FY22 to Rs 430 crore in FY26, a compound annual growth rate of 20.8%. Net profit grew from Rs 5.2 crore in FY22 to Rs 45.8 crore in FY26, which works out to a compound annual growth rate of 72.1%. The company has a return on equity of 15.8%, a debt to equity ratio of 0.11 and a market capitalisation of Rs 3,722 crore. The stock trades at a P\/E of 111.0, above the industry P\/E of 48.1. Looking ahead, the company is moving up the value chain into defence and space propellants, which carry higher margins than civil explosives. Orders from strategic programmes and capacity expansion support the plan.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying cement, drug ingredient and explosives stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying cement, drug ingredient and explosives stocks. Raw material costs. Ingredient and packaging prices can move margins. Regulatory approvals. Plant inspections and approvals can affect supplies. Order timing. Defence and space orders can shift between periods. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of cement, drug ingredient and explosives stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 16 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Cement, Drug Ingredient and Explosives Stocks with a strong future roadmap: JK Cement, Granules India and Premier Explosives. Compare price, valuation, return on equity and revenue growth as of 16 November 2026.<\/p>\n","protected":false},"author":34,"featured_media":350422,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[3803,25010,7058,25012,25009,9050,8484,25013,13955,25011],"class_list":["post-350423","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-best-stocks","tag-building-cement","tag-cement","tag-construction-material","tag-drug-ingredient-and-explosives-stocks","tag-granules-india","tag-jk-cement","tag-pharma-ingredients-and-defence-supplies-stocks","tag-premier-explosives","tag-tablet-maker-and-defence-propellant-shares"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["350422"],"rank_math_title":["Cement, Drug Ingredient and Explosive Stocks"],"rank_math_description":["Compare 3 cement, drug ingredient and explosives stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 16 Nov 2026."],"rank_math_focus_keyword":["cement, drug ingredient and explosives stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-cement-and-wall-putty-maker-pharmaceutical-ingredients-company-and-defence.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/350423","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=350423"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/350423\/revisions"}],"predecessor-version":[{"id":350424,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/350423\/revisions\/350424"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/350422"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=350423"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=350423"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=350423"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}